The angiotensinogen gene M235T polymorphism and development of preeclampsia/eclampsia: A meta-analysis and meta-regression of observational studies

Journal of Hypertension

Volumn 26, Issue 9, 2008, Pages 1726-1734

  Zafarmand, Mohammad Hadi ^a,b   Nijdam, Marie Elise ^a   Franx, Arie ^c   Grobbee, Diederick E ^a   Bots, Michiel L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c CPRLab   (Netherlands)

Author keywords

Angiotensinogen gene; Genetics; Meta analysis; Meta regression; Polymorphism; Pregnancy hypertension

Indexed keywords

ANGIOTENSINOGEN;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; DOMINANT GENE; ECLAMPSIA; EMBASE; GENE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC MODEL; HOMOZYGOTE; HUMAN; HYPERTENSION; MEDLINE; OBSERVATIONAL STUDY; POPULATION; PREECLAMPSIA; PRIORITY JOURNAL; PROBABILITY; PUBLISHING; RECESSIVE GENE; RISK ASSESSMENT; SYSTEMATIC REVIEW; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MATERNAL HYPERTENSION; META ANALYSIS; PREGNANCY; REGRESSION ANALYSIS;

ANGIOTENSINOGEN; ECLAMPSIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; REGRESSION ANALYSIS;

EID: 58149229530     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283009ca5     Document Type: Article

References (44)

1. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP,Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
2. Caul?eldM, Lavender P, Newell-Price J, FarrallM, Kamdar S, Daniel H, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995; 96:687-692.
3. Staessen JA, Kuznetsova T,Wang JG, Emelianov D, Vlietinck R, Fagard R. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17:9-17.
4. NHBPEP. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
5. Roberts JM, Lain KY. Recent Insights into the pathogenesis of preeclampsia. Placenta 2002; 23:359-372.
6. Arngrimsson R, Purandare S, Connor M, Walker JJ, Bjornsson S, Soubrier F, et al. Angiotensinogen: a candidate gene involved in preeclampsia? Nat Genet 1993; 4:114-115.
7. Bouba I, Makrydimas G, Kalaitzidis R, Lolis DE,Siamopoulos KC, Georgiou I. Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; ,110:8-11.
8. Procopciuc L, Jebeleanu G, Surcel I, Puscas M. Angiotensinogen gene M235T variant and preeclampsia in Romanian pregnant women. J Cell Mol Med 2002; 6:383-388.
9. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4:59-61.
10. Kobashi G, Hata A, Shido K, Kato EH, Yamada H, Fujimoto S, et al. Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: implication of a racial difference and signi?cance of an age factor. Am J Med Genet 1999; 86:232-236.
11. Morgan L, Crawshaw S, Baker PN, Broughton PF, Kalsheker N. Maternal and fetal angiotensinogen gene allele sharing in preeclampsia. Br J Obstet Gynaecol 1999; 106:244-251.
12. Choi H, Kang JY, Yoon HS, Han SS, Whang CS, Moon IG, et al. Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. J KoreanMed Sci 2004; 19:253-257.
13. Guo G, Wilton AN, Fu Y, Qiu H, Brennecke SP, Cooper DW. Angiotensinogen gene variation in a population case-control study of preeclampsia/eclampsia in Australians and Chinese. Electrophoresis 1997; 18:1646-1649.
14. Suzuki Y, Tanemura M, Suzuki Y, Murakami I, Suzumori K. Is angiotensinogen gene polymorphism associated with hypertension in pregnancy? Hypertens Pregnancy 1999; 18:261-271.
15. Wang L, Feng Y, Zhang Y, Zhou H, Jiang S, Niu T, et al. Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia. Am J Obstet Gynecol 2006; 195:162-171.
16. Bashford MT, He?er LA, Vertrees TW, Roa BB, Gregg AR. Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia. Am J Obstet Gynecol 2001; 184:1345-1350.
17. Roberts CB, Rom L, Moodley J, Pegoraro RJ. Hypertension-related gene polymorphisms in preeclampsia, eclampsia and gestational hypertension in Black South African women. J Hypertens 2004; 22:945-948.
18. Levesque S, Moutquin JM, Lindsay C, Roy MC, Rousseau F. Implication of an AGT haplotype in a multigene association study with pregnancy hypertension. Hypertension 2004; 43:71-78.
19. Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 2006; 163:300-309.
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
21. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54:1046-1055.
22. Tempfer CB, Jirecek S, Riener EK, Zeisler H, Denschlag D, He?er L, et al. Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study. J Soc Gynecol Investig 2004; 11: 227-231.
23. Kim YJ, Park MH, Park HS, Lee KS, Ha EH, Pang MG. Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin- converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women. Eur J Obstet Gynecol Reprod Biol 2004; 116:48-53.
24. Hillermann R, Carelse K, Gebhardt GS. The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in preeclampsia. J Hum Genet 2005; 50:415-419.
25. Pridjian G, Puschett JB. Preeclampsia Part 2: experimental and genetic considerations. Obstet Gynecol Surv 2002; 57:619-640.
26. Pfab T, Chen YP, Slowinski T, Richter CM, Godes M, Arck PC, et al. Impact of genes related to immune tolerance and in?ammation (tumour necrosis factor-alpha, interleukin-6) on blood pressure, protein excretion and oedema in pregnancy. J Hypertens 2005; 23:2187-2191.
27. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
28. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, et al. Risk factors associated with preeclampsia in healthy nulliparous women: the Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997; 177:1003-1010.
29. Mangos GJ. Cardiovascular disease following preeclampsia: understanding the mechanisms. J Hypertens 2006; 24:639-641.
30. Brown DW, Dueker N, Jamieson DJ, Cole JW,Wozniak MA, Stern BJ, et al. Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study. Stroke 2006; 37:1055-1059.
31. The Genetics of Pre-eclampsia (GOPEC) Consortium. Babies, preeclamptic mothers and grandparents: a three-generation phenotyping study. J Hypertens 2007; 25:849-854.
32. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after preeclampsia: population based cohort study. BMJ 2001; 323:1213-1217.
33. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74:772-776.
34. Smith GC, Pell JP,Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet 2001; 357:2002-2006.
35. Lampinen KH, Ronnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of preeclampsia. J Hypertens 2006; 24:751-756.
36. Manten GTRSJ, Voorbij HAM, Visser GHA, Bruinse HW, Franx A. Lipoprotein (a) and other risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy 2004; 23 (Suppl 1):S51.
37. Rodie VA, Freeman DJ, Sattar N, Greer IA. Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 2004; 175:189-202.
38. Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 2003; 42:39-42.
39. Sikkema JMDVH, Huisjes AJ, Van Wijk NG, Visser GH, Franx A, Bruinse HW. Insulin resistance in women with a history of early and late onset preeclampsia. J Soc Gynecol Invest 2001; 8:580.
40. Barden AE, Beilin LJ, Ritchie J, Walters BN, Michael C. Does a predisposition to the metabolic syndrome sensitize women to develop preeclampsia? J Hypertens 1999; 17:1307-1315.
41. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002; 325:157-160.
42. Kobashi G. Genetic and environmental factors associated with the development of hypertension in pregnancy. J Epidemiol 2006; 16:1-8.
43. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006; 295:676-680.
44. Morgan T, Craven C, Lalouel JM,Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in ?rst-trimester decidua. Am J Obstet Gynecol 1999; 180:95-102.